BIOMAT Database Logo BIOMAT Database Logo

Ceftaroline Pharmacokinetics in a Critically Ill Adult Receiving Continuous Venovenous Hemodiafiltration. 2022

Alexander R Cain, and Lauren M Finoli, and Anthony Guarascio, and Osakpolor Ogbebor, and Nathan R Shively, and Tyler Andrea, and Derek N Bremmer

UI MeSH Term Description Entries
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000079664 Continuous Renal Replacement Therapy Procedures with continuous blood purification (e.g., dialysis, filtration or perfusion) via vascular access designed to mimic kidney function in kidney diseases (e.g., ACUTE RENAL FAILURE and poisoning). CAVHD,CRRT Technique,CVVH Technique,CVVHD,CVVHDF,Continuous Arterio-Venous Ultrafiltration,Continuous RRT,Continuous Renal Replacement Procedure,Continuous Veno-Venous Hemodiafiltration,Continuous Veno-Venous Hemodialysis,Continuous Veno-Venous Hemofiltration,Continuous Venovenous Hemodiafiltration,Continuous Venovenous Hemodialysis,Continuous Venovenous Hemofiltration,Hemofiltration, Continuous Arteriovenous,SCUF Technique,Slow Continuous Ultrafiltration,Arterio-Venous Ultrafiltration, Continuous,Arteriovenous Hemofiltration, Continuous,CVVH Techniques,Continuous Arterio Venous Ultrafiltration,Continuous Arterio-Venous Ultrafiltrations,Continuous Arteriovenous Hemofiltration,Continuous Arteriovenous Hemofiltrations,Continuous RRTs,Continuous Veno Venous Hemodiafiltration,Continuous Veno Venous Hemodialysis,Continuous Veno Venous Hemofiltration,Continuous Veno-Venous Hemodiafiltrations,Continuous Veno-Venous Hemodialyses,Continuous Veno-Venous Hemofiltrations,Continuous Venovenous Hemodiafiltrations,Continuous Venovenous Hemodialyses,Continuous Venovenous Hemofiltrations,Hemodiafiltration, Continuous Veno-Venous,Hemodiafiltration, Continuous Venovenous,Hemodialysis, Continuous Veno-Venous,Hemodialysis, Continuous Venovenous,Hemofiltration, Continuous Veno-Venous,Hemofiltration, Continuous Venovenous,RRT, Continuous,SCUF Techniques,Slow Continuous Ultrafiltrations,Ultrafiltration, Continuous Arterio-Venous,Veno-Venous Hemodiafiltration, Continuous,Veno-Venous Hemodialyses, Continuous,Veno-Venous Hemodialysis, Continuous,Veno-Venous Hemofiltration, Continuous,Venovenous Hemodiafiltration, Continuous,Venovenous Hemodialysis, Continuous,Venovenous Hemofiltration, Continuous
D000097583 Ceftaroline A fifth-generation cephalosporin antibacterial agent that is used to treat skin infections caused by bacteria in adults and newborns. Ceftaroline has a 1,3-thiazolidine ring attached to the C-7 position of its cephalosporin core. Ceftaroline Fosamil,Zinforo,PPI-0903,PPI0903,T 91825,T-91825,T91825,TAK-599,TAK599,Teflaro,91825, T,Fosamil, Ceftaroline,PPI 0903,TAK 599
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016638 Critical Illness A disease or state in which death is possible or imminent. Critically Ill,Critical Illnesses,Illness, Critical,Illnesses, Critical
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

Alexander R Cain, and Lauren M Finoli, and Anthony Guarascio, and Osakpolor Ogbebor, and Nathan R Shively, and Tyler Andrea, and Derek N Bremmer
Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration.
January 2013, Antimicrobial agents and chemotherapy,
Alexander R Cain, and Lauren M Finoli, and Anthony Guarascio, and Osakpolor Ogbebor, and Nathan R Shively, and Tyler Andrea, and Derek N Bremmer
Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration.
January 2014, Antimicrobial agents and chemotherapy,
Alexander R Cain, and Lauren M Finoli, and Anthony Guarascio, and Osakpolor Ogbebor, and Nathan R Shively, and Tyler Andrea, and Derek N Bremmer
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration.
November 2005, Antimicrobial agents and chemotherapy,
Alexander R Cain, and Lauren M Finoli, and Anthony Guarascio, and Osakpolor Ogbebor, and Nathan R Shively, and Tyler Andrea, and Derek N Bremmer
Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
February 2002, Pharmacotherapy,
Alexander R Cain, and Lauren M Finoli, and Anthony Guarascio, and Osakpolor Ogbebor, and Nathan R Shively, and Tyler Andrea, and Derek N Bremmer
Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients.
January 2014, Antimicrobial agents and chemotherapy,
Alexander R Cain, and Lauren M Finoli, and Anthony Guarascio, and Osakpolor Ogbebor, and Nathan R Shively, and Tyler Andrea, and Derek N Bremmer
Pharmacokinetics of flucytosine in a critically ill patient on continuous venovenous hemodiafiltration.
April 2020, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Alexander R Cain, and Lauren M Finoli, and Anthony Guarascio, and Osakpolor Ogbebor, and Nathan R Shively, and Tyler Andrea, and Derek N Bremmer
Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF).
January 2010, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Alexander R Cain, and Lauren M Finoli, and Anthony Guarascio, and Osakpolor Ogbebor, and Nathan R Shively, and Tyler Andrea, and Derek N Bremmer
Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis.
January 2011, Critical care medicine,
Alexander R Cain, and Lauren M Finoli, and Anthony Guarascio, and Osakpolor Ogbebor, and Nathan R Shively, and Tyler Andrea, and Derek N Bremmer
Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
September 2004, British journal of clinical pharmacology,
Alexander R Cain, and Lauren M Finoli, and Anthony Guarascio, and Osakpolor Ogbebor, and Nathan R Shively, and Tyler Andrea, and Derek N Bremmer
Lacosamide Pharmacokinetics in a Critically Ill Patient Receiving Continuous Venovenous Hemofiltration.
February 2018, Pharmacotherapy,
Copied contents to your clipboard!